BSB
GSK icon

Bangor Savings Bank’s GSK GSK Stock Holding History

Bangor Savings Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99K Hold
57
– – ﹤0.01% 492
2026
Q1 		$3.15K Sell
57
-634
-92% -$34.4K ﹤0.01% 498
2025
Q4 		$33.9K Hold
691
– – ﹤0.01% 331
2025
Q3 		$29.8K Sell
691
-150
-18% -$5.86K ﹤0.01% 341
2025
Q2 		$32.3K Hold
841
– – ﹤0.01% 332
2025
Q1 		$32.6K Buy
841
+100
+13% +$3.66K ﹤0.01% 328
2024
Q4 		$25.1K Hold
741
– – ﹤0.01% 358
2024
Q3 		$30.3K Sell
741
-9
-1% -$368 ﹤0.01% 342
2024
Q2 		$28.9K Hold
750
– – ﹤0.01% 332
2024
Q1 		$32.2K Hold
750
– – ﹤0.01% 324
2023
Q4 		$27.8K Hold
750
– – ﹤0.01% 341
2023
Q3 		$27.2K Hold
750
– – ﹤0.01% 343
2023
Q2 		$26.7K Buy
750
+85
+13% +$3.05K ﹤0.01% 358
2023
Q1 		$23.7K Buy
665
+656
+7,289% +$22.9K ﹤0.01% 364
2022
Q4 		$0 Buy
+9
New +$300 ﹤0.01% 534
2022
Q3 		– Sell
-10
Closed -$1K – 534
2022
Q2 		$1K Buy
+10
New +$552 ﹤0.01% 502
2015
Q4 		– Sell
-5,294
Closed -$254K – 140
2015
Q3 		$254K Buy
5,294
+286
+6% +$14.9K 0.06% 126
2015
Q2 		$261K Sell
5,008
-701
-12% -$39.5K 0.06% 132
2015
Q1 		$329K Sell
5,709
-25,125
-81% -$1.44M 0.08% 122
2014
Q4 		$1.65M Buy
30,834
+265
+0.9% +$14.8K 0.42% 46
2014
Q3 		$1.76M Sell
30,569
-898
-3% -$55.1K 0.47% 43
2014
Q2 		$2.1M Sell
31,467
-547
-2% -$37K 0.55% 34
2014
Q1 		$2.14M Sell
32,014
-176
-0.5% -$11.9K 0.64% 30
2013
Q4 		$2.15M Buy
32,190
+764
+2% +$49.5K 0.6% 33
2013
Q3 		$1.97M Sell
31,426
-480
-2% -$30.9K 0.6% 34
2013
Q2 		$1.99M Buy
+31,906
New +$2.03M 0.64% 32

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bangor Savings Bank's GSK Position: Q2 2026 in Review

Bangor Savings Bank held its GSK (GSK) position steady in Q2 2026 at 57 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Bangor Savings Bank first reported a position in GSK in Q2 2013 and has held it in 26 quarters since. The position peaked at $2.15M in Q4 2013. 156 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Bangor Savings Bank held 57 shares of GSK worth $2.99K as of Q2 2026.
  • Bangor Savings Bank left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Bangor Savings Bank's portfolio in Q2 2026, its #492 holding.
  • Bangor Savings Bank first reported a position in GSK in Q2 2013 and has held it in 26 quarters since.
  • Bangor Savings Bank's GSK position peaked at $2.15M in Q4 2013.
  • 156 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bangor Savings Bank's 13F filing for Q2 2026, filed 6 Jul 2026.